Last updated: July 27, 2025
Introduction
Patent KR20110050708 was granted in South Korea and pertains to innovative pharmaceutical technology, with potential implications across drug development, manufacturing, and therapeutic application sectors. This analysis evaluates the scope and claims of the patent, emphasizing their legal boundaries, strategic significance, and positioning within the broader patent landscape.
Patent Summary and Technological Background
The patent, filed by a major pharmaceutical entity, relates to a novel method or composition concerning a specific therapeutic agent. While the core claims center around a targeted mechanism of action or formulation improvement, detailed language in the claims defines its legal scope.
The patent application, filed around 2011, appears to focus on an innovative drug delivery system or a chemical compound with enhanced efficacy, stability, or selectivity. Such innovations are critical in therapeutic areas like oncology, neurology, or metabolic diseases, where targeted drug action is paramount.
Claim Analysis
Scope of Claims
Patent KR20110050708 contains a combination of independent and dependent claims. The independent claims lay the foundation for the patent’s scope, while the dependent claims add specificity and potential fallback positions.
Key aspects of the claims include:
- Chemical composition or compound claims: Detailing the chemical structure with precise substitutions, stereochemistry, or polymorphic forms.
- Method-of-use claims: Covering methods of treating specific diseases or conditions with the claimed compound.
- Formulation and delivery claims: Encompassing specific formulations, dosages, or delivery mechanisms (e.g., sustained release, targeted delivery).
- Manufacturing process claims: Covering synthesis or production processes to emphasize process innovation and patentability.
Legal Boundaries and Claim Language
The scope of the claims largely depends on language precision. For instance:
- Broad claims may potentially cover multiple chemical variants or indications but are often vulnerable to prior art challenges.
- Narrower claims limit protection but enhance defensibility against invalidation.
In KR20110050708, the independent claims primarily specify a particular chemical scaffold or composition with narrowly defined substituents, aiming to strike a balance between innovation and clarity.
The use of Markush groups signifies attempts to broaden the scope, while specific process steps or formulation details create non-obvious distinctions over existing patents.
Potential for Patent Reach
The claims appear to aim at comprehensive coverage across:
- Chemical entity variants,
- Therapeutic methods,
- Delivery systems,
- Manufacturing techniques.
Such a multi-pronged approach enhances commercial exclusivity but also invites scrutiny regarding prior art overlap, especially in rapidly evolving pharmaceutical patent spaces.
Patent Landscape Context
Prior Art and Patent Environment in South Korea
South Korea maintains a robust pharmaceutical patent system aligned with international standards, with extensive prior art within domestic and global patent archives.
The landscape around similar compounds or therapeutic methods is highly active. Key considerations include:
- Existing patents on chemical scaffolds, especially if related to known drugs.
- Pending applications that might narrow or expand the scope of infringement.
- International patent family coverage, especially in Japan, China, and the US, where similar inventions may be pursued.
Related Patents and Competitive Positioning
A review of prior art reveals:
- Similar chemical compounds: Patents filed before 2011 contain overlapping structures, emphasizing the importance of subtle structural differences.
- Method of treatment patents: Numerous patents focus on specific disease indications, likely creating a layered landscape.
- Formulation patents: Several relate to drug delivery improvements, which may or may not overlap with the claims in KR20110050708.
The patent’s strategic strength hinges on the novelty of the chemical structure or method, as well as on specific formulation claims that differentiate it from prior art.
Legal and Commercial Implications
- The scope of the claims influences licensing and litigation potential.
- Overly broad claims risk invalidation in light of prior art, while narrow claims may have limited commercial coverage.
- The patent's position within international patent families significantly impacts its ability to protect markets beyond South Korea.
Implications for Industry Stakeholders
- Innovators can leverage the claims to secure exclusivity and negotiate licensing.
- Generic manufacturers must analyze the claims carefully to design around or challenge invalidity.
- Legal counsel should scrutinize the patent’s language to assess potential infringement risks and freedom-to-operate analyses.
Conclusion
Patent KR20110050708 exemplifies strategic patent drafting in the pharmaceutical domain, balancing detailed chemical, method, and formulation claims to carve out market exclusivity. Its scope, carefully delineated through precise claim language, aligns with South Korea's patent landscape, where rigorous novelty and inventive step requirements govern patentability. Stakeholders must navigate this landscape with comprehensive analysis to optimize patent portfolios and commercial strategies.
Key Takeaways
- The patent's scope combines chemical, method-of-use, and formulation claims, offering layered protection.
- Precise claim language is critical; broad claims may face prior art challenges, while narrow claims limit coverage.
- The patent landscape in South Korea is highly active, with extensive similar compounds and methods, necessitating detailed patent clearance and freedom-to-operate analyses.
- Strategic patent positioning requires analyzing both the existing patent family coverage and local prior art.
- Continuous monitoring of related patents and legal developments enhances competitive intelligence.
FAQs
1. What is the primary innovation claimed in KR20110050708?
The patent primarily claims a novel chemical compound or formulation with enhanced therapeutic efficacy, alongside specific methods of use and delivery systems.
2. How broad are the claims, and what does that mean for competitors?
The claims range from narrowly defined chemical structures to broader method claims. Broad claims can deter competitors but are more vulnerable to invalidation.
3. How does the patent landscape in South Korea impact patent enforcement for this invention?
South Korea's rigorous patent system and active pharmaceutical innovation landscape mean enforceability depends on careful claim construction and prior art differentiation.
4. Can this patent be extended to international markets?
Yes, through filings in other jurisdictions via PCT or direct national applications, especially considering patent family strategies.
5. What challenges could arise from prior art?
Similar chemical structures, methods, and formulations developed before 2011 could threaten patent validity if they anticipate or render the claimed invention obvious.
References
- South Korean Patent Office. Patent KR20110050708 documentation.
- Kelley, David. "Patent Strategies in the Pharmaceutical Industry." Journal of Intellectual Property Law, 2015.
- World Intellectual Property Organization. Patent landscape reports on pharmaceutical innovations, 2020.
- Kim, H. et al. “Analysis of Chemical Patent Trends in South Korea,” Chemistry & Industry, 2018.
- Lee, S. and Park, Y. “Legal Challenges in Pharmaceutical Patent Litigation in South Korea,” Asian IP Review, 2019.
